I C U Medical Inc (ICUI) 108.13 $ICUI
Hologic: FDA Okays Procleix Zika Virus Test under IND Study
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:51AM CDT
Hologic's (HOLX) Procleix Zika Virus Test was approved under FDA???s Investigational New Drug (IND) study protocol to detect the presence of Zika virus in donated blood.
ICUI: 108.13 (+3.15), BAX: 45.96 (+1.02), LMAT: 14.82 (+0.13), HOLX: 35.62 (+1.51)
Hill-Rom Introduces VisiVest, First Connected Airways System
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:19AM CDT
Hill-Rom Holdings, Inc. (HRC) recently launched VisiVest System, the world's first wirelessly connected airway clearance system.
ICUI: 108.13 (+3.15), LMAT: 14.82 (+0.13), NUVA: 58.86 (+1.07), HRC: 52.06 (+0.78)
Hologic's Zika Virus Test Gets FDA Nod for Emergency Use
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 7:58AM CDT
Hologic (HOLX) will run the Aptima Zika virus test on its market leading Panther platform, which substantially reduces hands-on time for laboratories and the potential for manual errors.
ICUI: 108.13 (+3.15), BAX: 45.96 (+1.02), LMAT: 14.82 (+0.13), HOLX: 35.62 (+1.51)
Bruker Well Poised on Product Innovation amid Currency Woes
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 6:23AM CDT
On Jun 14, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR).
ICUI: 108.13 (+3.15), LMAT: 14.82 (+0.13), BRKR: 24.40 (+0.14), NUVA: 58.86 (+1.07)
Boston Scientific: Restructuring Plan, Global Growth Impress
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 6:14AM CDT
On Jun 13, 2016, we issued an updated research report on Boston Scientific Corporation (BSX).
BSX: 22.97 (+0.31), ICUI: 108.13 (+3.15), BAX: 45.96 (+1.02), LMAT: 14.82 (+0.13)
PetMed Remains Strong on New Order & Reorder Sales Gain
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 10:15AM CDT
On Jun 13, 2016, we issued an updated research report on PetMed Express (PETS).
ICUI: 108.13 (+3.15), PETS: 18.50 (+0.09), LMAT: 14.82 (+0.13), NUVA: 58.86 (+1.07)
Zimmer Biomet's Spine Business to Get a Boost with LDR Buy
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 6:00AM CDT
Zimmer Biomet Holdings, Inc. (ZBH) has entered into a definitive agreement to acquire LDR Holding Corp. (LDRH) for a total deal value of $1 billion.
BSX: 22.97 (+0.31), ICUI: 108.13 (+3.15), ZBH: 120.92 (+2.29), LDRH: 37.03 (+0.02)
NuVasive to Strengthen Spine Service Line with Biotronic Buy
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 7:17AM CDT
NuVasive, Inc. (NUVA) recently entered into a definitive agreement to acquire privately held Biotronic NeuroNetwork.
BSX: 22.97 (+0.31), ICUI: 108.13 (+3.15), BAX: 45.96 (+1.02), NUVA: 58.86 (+1.07)
Abaxis (ABAX): Solid Veterinary Show Despite Global Hiccups
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:01AM CDT
On Jun 3, 2016, we issued an updated research report on Abaxis, Inc. (ABAX). The stock currently carries a Zacks Rank #4 (Sell).
ICUI: 108.13 (+3.15), ABAX: 47.11 (+1.81), LMAT: 14.82 (+0.13), NUVA: 58.86 (+1.07)
Medtronic (MDT) Posts Solid Q4; Covidien Synergy Continues
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 6:31AM CDT
On Jun 3, 2016, we issued an updated research report on Medtronic plc (MDT).
BSX: 22.97 (+0.31), ICUI: 108.13 (+3.15), MDT: 85.77 (+1.51), LMAT: 14.82 (+0.13)
Medtronic (MDT) Beats Q4 Earnings & Revenue Estimates
Zacks Equity Research - Zacks Investment Research - Tue May 31, 8:01AM CDT
Medtronic's (MDT) fourth-quarter fiscal 2016 adjusted earnings per share (EPS) came in at $1.27, a penny ahead of the Zacks Consensus Estimate.
BSX: 22.97 (+0.31), ICUI: 108.13 (+3.15), MDT: 85.77 (+1.51), LMAT: 14.82 (+0.13)
NuVasive Poised on Solid International Sales, Scope in Spine
Zacks Equity Research - Zacks Investment Research - Tue May 31, 6:01AM CDT
On May 30, 2016, we updated our research report on NuVasive, Inc. (NUVA).
BSX: 22.97 (+0.31), ICUI: 108.13 (+3.15), LMAT: 14.82 (+0.13), NUVA: 58.86 (+1.07)
Medtronic (MDT): Will Currency Woes Hurt Q4 As Well?
Zacks Equity Research - Zacks Investment Research - Fri May 27, 6:26AM CDT
On May 26, 2016, we issued an updated research report on Medtronic plc (MDT).
BSX: 22.97 (+0.31), ICUI: 108.13 (+3.15), MDT: 85.77 (+1.51), LMAT: 14.82 (+0.13)
Abaxis (ABAX) Posts Solid Q4 amid International Headwind
Zacks Equity Research - Zacks Investment Research - Wed May 25, 5:28AM CDT
On May 18, 2016, we issued an updated research report on Abaxis, Inc. (ABAX).
ICUI: 108.13 (+3.15), ABAX: 47.11 (+1.81), LMAT: 14.82 (+0.13), NUVA: 58.86 (+1.07)
Zimmer Biomet: Strong Q1, Integration Synergy Continues
Zacks Equity Research - Zacks Investment Research - Mon May 23, 6:39AM CDT
On May 23, 2016, we issued an updated research report on Zimmer Biomet Holdings, Inc. (ZBH).
BSX: 22.97 (+0.31), ICUI: 108.13 (+3.15), ZBH: 120.92 (+2.29), NUVA: 58.86 (+1.07)
Medical Stocks' Q1 Earnings Releases on May 10: ICUI, ZLTQ
Zacks Equity Research - Zacks Investment Research - Mon May 09, 9:44AM CDT
The two popular names in the medical space, gearing up to report results on May 10, are ICUI and ZLTQ.
ICUI: 108.13 (+3.15), ZLTQ: 27.34 (+0.31)
ICU Medical, Inc. Announces Time of First Quarter 2016 Earnings Call
GlobeNewswire - Tue Apr 19, 3:05PM CDT
ICU Medical, Inc., (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced the time of its first quarter 2016 earnings release conference call.
ICUI: 108.13 (+3.15)
B. Braun and ICU Medical Sign Expanded Long-Term International Distribution Agreement
PR Newswire - Mon Mar 21, 7:00AM CDT
ICU Medical Inc. (NASDAQ: ICUI) today announced that it has entered into a long-term distribution agreement with B. Braun Melsungen AG, giving B. Braun distribution rights to promote ICU Medical's SwabCap® disinfecting cap for needlefree connectors in selected countries outside the United States. Under the expanded agreement, customers will be able to purchase the SwabCap family of products from B. Braun in more than 30 countries around the world.
ICUI: 108.13 (+3.15)
Shares of ICUI Down 13.3% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Mar 04, 5:48PM CST
SmarTrend identified a Downtrend for ICU Medical (NASDAQ:ICUI) on January 7th, 2016 at $106.19. In approximately 2 months, ICU Medical has returned 13.29% as of today's recent price of $92.07.
ICUI: 108.13 (+3.15)
Omnicell: Sales, Acquisitions Impress; Margin Pressure Lingers
Zacks Equity Research - Zacks Investment Research - Fri Feb 19, 1:50PM CST
On Feb 17, 2016, we issued an updated research report on Omnicell, Inc. (OMCL).
ICUI: 108.13 (+3.15), INSY: 13.07 (+0.29), BAX: 45.96 (+1.02), OMCL: 33.51 (+0.75)
Hologic: FDA Okays Procleix Zika Virus Test under IND Study
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:51AM CDT
Hologic's (HOLX) Procleix Zika Virus Test was approved under FDA???s Investigational New Drug (IND) study protocol to detect the presence of Zika virus in donated blood.
ICUI: 108.13 (+3.15), BAX: 45.96 (+1.02), LMAT: 14.82 (+0.13), HOLX: 35.62 (+1.51)
Hill-Rom Introduces VisiVest, First Connected Airways System
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:19AM CDT
Hill-Rom Holdings, Inc. (HRC) recently launched VisiVest System, the world's first wirelessly connected airway clearance system.
ICUI: 108.13 (+3.15), LMAT: 14.82 (+0.13), NUVA: 58.86 (+1.07), HRC: 52.06 (+0.78)
Hologic's Zika Virus Test Gets FDA Nod for Emergency Use
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 7:58AM CDT
Hologic (HOLX) will run the Aptima Zika virus test on its market leading Panther platform, which substantially reduces hands-on time for laboratories and the potential for manual errors.
ICUI: 108.13 (+3.15), BAX: 45.96 (+1.02), LMAT: 14.82 (+0.13), HOLX: 35.62 (+1.51)
Bruker Well Poised on Product Innovation amid Currency Woes
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 6:23AM CDT
On Jun 14, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR).
ICUI: 108.13 (+3.15), LMAT: 14.82 (+0.13), BRKR: 24.40 (+0.14), NUVA: 58.86 (+1.07)
Boston Scientific: Restructuring Plan, Global Growth Impress
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 6:14AM CDT
On Jun 13, 2016, we issued an updated research report on Boston Scientific Corporation (BSX).
BSX: 22.97 (+0.31), ICUI: 108.13 (+3.15), BAX: 45.96 (+1.02), LMAT: 14.82 (+0.13)
PetMed Remains Strong on New Order & Reorder Sales Gain
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 10:15AM CDT
On Jun 13, 2016, we issued an updated research report on PetMed Express (PETS).
ICUI: 108.13 (+3.15), PETS: 18.50 (+0.09), LMAT: 14.82 (+0.13), NUVA: 58.86 (+1.07)
Zimmer Biomet's Spine Business to Get a Boost with LDR Buy
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 6:00AM CDT
Zimmer Biomet Holdings, Inc. (ZBH) has entered into a definitive agreement to acquire LDR Holding Corp. (LDRH) for a total deal value of $1 billion.
BSX: 22.97 (+0.31), ICUI: 108.13 (+3.15), ZBH: 120.92 (+2.29), LDRH: 37.03 (+0.02)
NuVasive to Strengthen Spine Service Line with Biotronic Buy
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 7:17AM CDT
NuVasive, Inc. (NUVA) recently entered into a definitive agreement to acquire privately held Biotronic NeuroNetwork.
BSX: 22.97 (+0.31), ICUI: 108.13 (+3.15), BAX: 45.96 (+1.02), NUVA: 58.86 (+1.07)
Abaxis (ABAX): Solid Veterinary Show Despite Global Hiccups
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:01AM CDT
On Jun 3, 2016, we issued an updated research report on Abaxis, Inc. (ABAX). The stock currently carries a Zacks Rank #4 (Sell).
ICUI: 108.13 (+3.15), ABAX: 47.11 (+1.81), LMAT: 14.82 (+0.13), NUVA: 58.86 (+1.07)
Medtronic (MDT) Posts Solid Q4; Covidien Synergy Continues
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 6:31AM CDT
On Jun 3, 2016, we issued an updated research report on Medtronic plc (MDT).
BSX: 22.97 (+0.31), ICUI: 108.13 (+3.15), MDT: 85.77 (+1.51), LMAT: 14.82 (+0.13)
Medtronic (MDT) Beats Q4 Earnings & Revenue Estimates
Zacks Equity Research - Zacks Investment Research - Tue May 31, 8:01AM CDT
Medtronic's (MDT) fourth-quarter fiscal 2016 adjusted earnings per share (EPS) came in at $1.27, a penny ahead of the Zacks Consensus Estimate.
BSX: 22.97 (+0.31), ICUI: 108.13 (+3.15), MDT: 85.77 (+1.51), LMAT: 14.82 (+0.13)
NuVasive Poised on Solid International Sales, Scope in Spine
Zacks Equity Research - Zacks Investment Research - Tue May 31, 6:01AM CDT
On May 30, 2016, we updated our research report on NuVasive, Inc. (NUVA).
BSX: 22.97 (+0.31), ICUI: 108.13 (+3.15), LMAT: 14.82 (+0.13), NUVA: 58.86 (+1.07)
Medtronic (MDT): Will Currency Woes Hurt Q4 As Well?
Zacks Equity Research - Zacks Investment Research - Fri May 27, 6:26AM CDT
On May 26, 2016, we issued an updated research report on Medtronic plc (MDT).
BSX: 22.97 (+0.31), ICUI: 108.13 (+3.15), MDT: 85.77 (+1.51), LMAT: 14.82 (+0.13)
Abaxis (ABAX) Posts Solid Q4 amid International Headwind
Zacks Equity Research - Zacks Investment Research - Wed May 25, 5:28AM CDT
On May 18, 2016, we issued an updated research report on Abaxis, Inc. (ABAX).
ICUI: 108.13 (+3.15), ABAX: 47.11 (+1.81), LMAT: 14.82 (+0.13), NUVA: 58.86 (+1.07)
Zimmer Biomet: Strong Q1, Integration Synergy Continues
Zacks Equity Research - Zacks Investment Research - Mon May 23, 6:39AM CDT
On May 23, 2016, we issued an updated research report on Zimmer Biomet Holdings, Inc. (ZBH).
BSX: 22.97 (+0.31), ICUI: 108.13 (+3.15), ZBH: 120.92 (+2.29), NUVA: 58.86 (+1.07)
Medical Stocks' Q1 Earnings Releases on May 10: ICUI, ZLTQ
Zacks Equity Research - Zacks Investment Research - Mon May 09, 9:44AM CDT
The two popular names in the medical space, gearing up to report results on May 10, are ICUI and ZLTQ.
ICUI: 108.13 (+3.15), ZLTQ: 27.34 (+0.31)
ICU Medical, Inc. Announces Time of First Quarter 2016 Earnings Call
GlobeNewswire - Tue Apr 19, 3:05PM CDT
ICU Medical, Inc., (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced the time of its first quarter 2016 earnings release conference call.
ICUI: 108.13 (+3.15)
B. Braun and ICU Medical Sign Expanded Long-Term International Distribution Agreement
PR Newswire - Mon Mar 21, 7:00AM CDT
ICU Medical Inc. (NASDAQ: ICUI) today announced that it has entered into a long-term distribution agreement with B. Braun Melsungen AG, giving B. Braun distribution rights to promote ICU Medical's SwabCap® disinfecting cap for needlefree connectors in selected countries outside the United States. Under the expanded agreement, customers will be able to purchase the SwabCap family of products from B. Braun in more than 30 countries around the world.
ICUI: 108.13 (+3.15)
Shares of ICUI Down 13.3% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Mar 04, 5:48PM CST
SmarTrend identified a Downtrend for ICU Medical (NASDAQ:ICUI) on January 7th, 2016 at $106.19. In approximately 2 months, ICU Medical has returned 13.29% as of today's recent price of $92.07.
ICUI: 108.13 (+3.15)
Omnicell: Sales, Acquisitions Impress; Margin Pressure Lingers
Zacks Equity Research - Zacks Investment Research - Fri Feb 19, 1:50PM CST
On Feb 17, 2016, we issued an updated research report on Omnicell, Inc. (OMCL).
ICUI: 108.13 (+3.15), INSY: 13.07 (+0.29), BAX: 45.96 (+1.02), OMCL: 33.51 (+0.75)
